SYMPTOMS of MIS-C include inflammation of various organs, which can be fatal. However, treatments are available.
A study from a Washington, D.C., hospital finds that MIS-C disproportionately affects Black and Latino children. Much remains to be learned about MIS-C, including the best way to treat it.
Multisystem inflammatory syndrome in children (MIS-C) Trusted Source is one of the most severe and mystifying threats associated with SARS-CoV-2 infections. This potentially life threatening condition primarily affects people under 21 years.
It is characterized by the inflammation of the heart, lungs, brain, kidneys, eyes, skin, or gastrointestinal organs.
Although MIS-C can be successfully treated if detected early enough, it is a disease of exclusion, making diagnosis difficult.
Although children with MIS-C test positive for a current or recent SARS-CoV-2 infection, they may be asymptomatic, with no outward sign that infection has even occurred.
The Centers for Disease Control and Prevention (CDC) Trusted Source report that 3,724 children in the United States have been diagnosed with MIS-C as of May 2021.
The study found that heart complications, including systolic myocardial dysfunction and valvular regurgitation, frequently occurred in children critically ill with MIS-C.
Stay informed with live updates on the current Covid-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.
A study from Children’s National Hospital in Washington, D.C., finds that MIS-C disproportionately affects Black and Latino children, with Black children at significantly greater risk of MIS-C.
With this research, the study’s authors hoped to develop a clearer picture of the impact of MIS-C and to help identify patterns that could promote early detection and successful treatment.
